InvestorsHub Logo
Followers 22
Posts 4084
Boards Moderated 0
Alias Born 04/29/2016

Re: None

Friday, 11/10/2017 1:27:26 PM

Friday, November 10, 2017 1:27:26 PM

Post# of 232075
N =50 is a compromise from statistical significance to clinical significance, and even 50 is not a compelling data base for any analysis. PRO 140 IMO, will be the eighth choice on an ever revolving HAART approach. Physicians will be very reticent in adopting a N=50 drug before trying all the established HAART combinations. Habit and comfort precedes PRO 140, especially with a N=50 data base.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News